Comparison of Absolute Protein Abundances of Transporters and Receptors among Blood–Brain Barriers at Different Cerebral Regions and the Blood–Spinal Cord Barrier in Humans and Rats

Abstract

This work was designed to clarify the absolute abundances of transporters and receptors at different cerebral regions of the blood−brain barriers (BBB) and blood−spinal cord barrier (BSCB) in humans and rats, using physiologically relevant units (pmol/g tissue and fmol/cm 2 ); 39 and 29 proteins including tight-junction proteins and markers were quantified in human and rat capillary samples, respectively. Protein expression levels of almost all proteins were identical within a 2-fold range between BBB and BSCB in rats, while many proteins showed >2-fold smaller expression levels in BSCB than BBB in humans. Protein expression levels of transporters and receptors in humans were remarkably smaller than those in rats in both BBB and BSCB in units of pmol/g tissue and fmol/cm 2 . Protein expression levels (fmol/cm 2 ) of MDR1 and BCRP at the BBB in humans were 9.88-fold and 5.23-fold smaller than those in rats, respectively. GLUT1 expression (pmol/g tissue) at cortical BBB in a human was 2.49-and 3.76-fold greater than that at white matter BBB and BSCB, respectively. INSR and LRP1 proteins were detected at cortical BBB, but not at white matter BBB or BSCB in humans. These findings throw light on regional differences and species differences in pharmacokinetics and physiological functions in the central nervous system. KEYWORDS: blood−spinal cord barrier (BSCB), blood−brain barrier (BBB), pmol/g tissue, fmol/cm 2 , species difference

Altered Blood-Brain Barrier and Blood-Spinal Cord Barrier Dynamics in Amyotrophic Lateral Sclerosis: Impact on Medication Efficacy and Safety

“…The BSCB is slightly more permeable than the BBB in mice (Pan, Banks & Kastin, 1997), likely attributed to reduced abundance of zonula occludens-1 and occludin (Ge & Pachter, 2006). Furthermore, the levels of efflux transporters and TJ proteins were reported higher in the human BBB relative to the BSCB (Uchida et al, 2020).…”

Neuroinflammation and Modulation Role of Natural Products After Spinal Cord Injury

“…Third, microvessels of the spinal cord possess glycogen deposits, which are not normally seen in cerebral vasculature. Lastly, BSCB processes have increased permeability compared with BBB, which might be explained by lower expressions of transporter molecular (P-glycoprotein), tight junction (TJ) and adherens junction (AJ) proteins (ZO-1, occludin, VE-cadherin, βcatenin) in endothelial cells 7,8 (Figure 2).…”

Brain Barriers and brain fluids research in 2020 and the fluids and barriers of the CNS thematic series on advances in in vitro modeling of the blood–brain barrier and neurovascular unit

“…Interestingly, Batiuk et al [18] used single-cell RNA sequencing to identify multiple astrocyte subtypes that vary across and within mouse brain regions raising the possibility of another level of cerebrovascular regulation. Uchida et al [19] recently described regional differences in transporter expression in brain capillaries from rats and humans. The extent that these changes are related to inherent differences at the endothelium or differences in signals from other cells of the NVU (e.g., astrocytes) merits investigation.…”